CN107496745A - A kind of Chinese medicine composition for treating heat asthma - Google Patents
A kind of Chinese medicine composition for treating heat asthma Download PDFInfo
- Publication number
- CN107496745A CN107496745A CN201710851970.6A CN201710851970A CN107496745A CN 107496745 A CN107496745 A CN 107496745A CN 201710851970 A CN201710851970 A CN 201710851970A CN 107496745 A CN107496745 A CN 107496745A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- root bark
- asthma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
Abstract
The present invention relates to the Chinese medicine composition for the treatment of heat asthma, can effectively solve the problems, such as the medication of heat asthma, its technical scheme solved is that the Chinese medicine composition is made up of the material medicine of following parts by weight meter：9~12 parts of Chinese ephedra, 30~45 parts of gypsum, 9~12 parts of almond, 12~15 parts of the root bark of white mulberry, 12~15 parts of the root bark of Chinese wolf-berry, 9~12 parts of polished rice, 9~12 parts of bulbus fritillariae cirrhosae, 12~15 parts of radix glehniae, 12~15 parts of the tuber of dwarf lilyturf, 6~9 parts of licorice, the component of the present composition uses natural Chinese medicine material, its preparation is easy, raw material supply is abundant, economic security, verify by clinic application, its is evident in efficacy, do not occur toxic side effect, drug safety, be to treat the innovation on heat asthma medicine.
Description
Technical field
The present invention relates to field of medicaments, particularly a kind of Chinese medicine composition for treating heat asthma.
Background technology
Western medicine thinks, bronchial astehma（bronchial asthma）It is by various kinds of cell (particularly mast cell, thermophilic
Eosinophil and T lymphocytes etc.) and cellular component participate in chronic inflammatory airway disease, such a inflammation in susceptible person
Can cause panting for recurrent exerbation, shortness of breath, it is uncomfortable in chest and（Or）The symptoms such as cough, occur or aggravate, air flue at night and morning more
A variety of stimulating factor reactivity are increased.But it can alleviate voluntarily or through controlling.Severe patient can developing over days to several weeks or in one day
For several times, patient is very painful for breaking-out.With the passing of time breaking-out can cause the vitals such as heart and brain that serious change occurs because of anoxic.
Asthma is one of chronic refractory disease of serious threat human physical and mental health, and its incidence of disease and case fatality rate are in
Ascendant trend year by year, the illness rate of China's asthma are up to 0.5%~5%, it is estimated that the whole nation there are about more than 1,000 ten thousand asthmatic patient.
The hazards of asthma include host factor（Inherent cause）In terms of environmental factor two, but most of asthmatic patient category
In allergic constitution.The clinical manifestation of asthma is divided into acute attack stage, chronic sustained phase and clinical relieving period, acute attack, treatment
May be fatal when not in time.Western medical treatment asthma mainly based on glucocorticoid medicine, although having certain curative effect, is grown
Phase takes, and side effects of pharmaceutical drugs can produce larger injury to human body, easily trigger other complication.Therefore, asthma drug is treated
The problem of improvement on thing is current urgent need to resolve.
The content of the invention
For the above situation, to solve the defect of prior art, the purpose of the present invention is just to provide one kind and treats hot heavy breathing
The Chinese medicine composition of asthma, can effectively solve the problems, such as the medication of heat asthma.
The traditional Chinese medical science thinks, the cause of disease not outer inside and outside two of asthma because：It is outer because heresy etc. when experiencing the six external factors which cause diseases, internal cause then by diet not
Section, feelings will are hindered, sexual intercourse overstrain, or natural endowment is weak, after serious disease prolonged illness etc..Its interpretation of the cause, onset and process of an illness also not outer positive deficiency of vital energy and excess of pathogen two
End.Three dirty deficiency of lung spleen kidney, mutually and mutually because disease, it is the positive deficiency of vital energy of meaning, is more common in the paracmasis；Six external factors which cause diseases diseases caused by external factors, it is strongly fragrant in phlegm and retained fluid fire-evil
And other various pessimal stimulations, it is meaning excess of pathogen, is more common in stage of attack.Heat panting, card category is outer to be slightly cold, lung stagnated phlegm heat, and heat evil is stopped up
Lung and cause cough and asthma even nares flaring, gurgling with sputum, asthma can not crouch, thirsty, there is sweat or lossless, and the sticky color of phlegm is yellow, tell it
It is unfavorable, rolling and rapid pulse, red tongue with yellowish fur person.Accordingly, the technical scheme that the present invention solves is that the Chinese medicine composition is by following weight
The material medicine of number meter is made：9~12 parts of Chinese ephedra, 30~45 parts of gypsum, 9~12 parts of almond, 12~15 parts of the root bark of white mulberry,
12~15 parts of bone skin, 9~12 parts of polished rice, 9~12 parts of bulbus fritillariae cirrhosae, 12~15 parts of radix glehniae, 12~15 parts of the tuber of dwarf lilyturf, licorice 6~9
Part.
The component of the present composition uses natural Chinese medicine material, and it is prepared, and easy, raw material supply is abundant, economic peace
Entirely.It follows the prescriptions principle of the traditional Chinese medical science, and various component drugs are taken after mixing it with water using being decocted in water for oral dose to use or powder is made.By clinic application
Checking, its is evident in efficacy, does not occur toxic side effect, drug safety, is to treat the innovation on heat asthma medicine.
Embodiment
The embodiment of the present invention is described in further detail with reference to embodiments.
Embodiment 1
The present invention in the specific implementation, is made up of the material medicine of following parts by weight meter：9 parts of Chinese ephedra, 30 parts of gypsum, almond
9 parts, 12 parts of the root bark of white mulberry, 12 parts of the root bark of Chinese wolf-berry, 9 parts of polished rice, 9 parts of bulbus fritillariae cirrhosae, 12 parts of radix glehniae, 12 parts of the tuber of dwarf lilyturf, 6 parts of licorice.
Embodiment 2
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter：Chinese ephedra 10g, gypsum 40g, almond
11g, root bark of white mulberry 14g, root bark of Chinese wolf-berry 13g, polished rice 10g, bulbus fritillariae cirrhosae 11g, radix glehniae 13g, tuber of dwarf lilyturf 13g, licorice 7g.
Embodiment 3
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter：Chinese ephedra 12g, gypsum 30g, almond
12g, root bark of white mulberry 15g, root bark of Chinese wolf-berry 12g, polished rice 9g, bulbus fritillariae cirrhosae 12g, radix glehniae 12g, tuber of dwarf lilyturf 12g, licorice 9g.Embodiment 4
The present invention in the specific implementation, can also be made up of the material medicine of following weight meter：Chinese ephedra 11g, gypsum 35g, almond
10g, root bark of white mulberry 13g, root bark of Chinese wolf-berry 14g, polished rice 11g, bulbus fritillariae cirrhosae 10g, radix glehniae 14g, tuber of dwarf lilyturf 14g, licorice 8g.
Chinese medicine composition of the present invention can a point two methods produce medicament.First, conventional decocting method, specific method are as follows：By group
The Chinese medicine material of side is put into container, adds cold water to cover 6 centimetres of powder, is soaked 20 minutes or so, is entered wardrobe and decoct, first using force
Fire decocts, and is used instead after boiling and gauze leaching concoction is used after being cooked by slow fire 20~30 minutes；Two decoct, and add water not have about 3 centimetres of powder,
Juice is taken after being decocted 15~20 minutes after water boiling.The concoction merging mixing that will be decocted twice.Two, which are formed into powder, takes after mixing it with water, specifically
Method is as follows：Material medicine is weighed by prescription amount first, then after putting it into drying baker processing being dried, with electronic crushing
All medicines are beaten powder by machine, sieving, collect fine powder, coarse powder are repeated to crush and sieve again, until fine powder is broken into, by all medicines
Powder bottling is standby.
In prescription of the present invention, Chinese ephedra is pungent scattered and micro- and the property of bitter drop, can external-open fur closing it is interior so that lung qi a surname is freely
The gas of superinverse drops, and it is often with the respectful drop of multiple lung department, therefore be apt to relieving asthma, to cure mainly the key medicine breathed with cough caused by sluggishness of lung-QI；Gypsum is pungent sweet big
It is cold, the heat of lung stomach is let out clearly to promote the production of body fluid；The bitter drop lung qi of almond, it is relieving cough and asthma, both help gypsum sedimentation descending, and help Chinese ephedra purging the lung of pathogenic fire hot again；
Lung Qi obstraction, burning hot pent-up specially enter lung channel, clear purging the lung of pathogenic fire heat is relieving cough and asthma in lung, therefore with the sweet cold drop of the root bark of white mulberry；The root bark of Chinese wolf-berry
Gan Han is clear to drop lung second of the three ten-day periods of the hot season fire；Bulbus fritillariae cirrhosae is sweet cold, clearing heat and moistening lung, preventing phlegm from forming and stopping coughing；Radix glehniae slight bitter cold nature, clearing heat and nourishing yin, moistening lung
Cough-relieving；The tuber of dwarf lilyturf is sweet cold, promoting production of body fluid and nourishing the lung cough-relieving；Polished rice, which escorts, to promote the production of body fluid；Licorice cares for shield stomach Qi, takes into account heat-clearing, and coordinating the drug actions of a prescription.Can
The medicine group compatibility seen in the present composition is precise and appropriate, is complemented each other using, and has synergy, plays facilitaing lung heat-clearing altogether,
The effect of relieving cough and asthma, for treat it is outer be slightly cold, lung stagnated phlegm heat, the heat panting of accumulation of heat in the lung is evident in efficacy.
Above-mentioned component science, reasonable compatibility, support mutually, there is facilitaing lung heat-clearing, it is relieving cough and asthma and other effects, effective for controlling
Heat asthma, good effect, drug safety are treated, and has obtained fully proving through clinical data, relevant clinical data is as follows：
First, general data：
Chinese medicine composition of the present invention is applied to clinical observation case 60, wherein man 25, female 35, one full year of life at age 14~65.
2nd, diagnostic criteria
L, often there are the premonitory symptoms such as sneeze, cough before breaking out, or night breaks out；Wheezing between larynx during breaking-out, expiratory dyspnea,
Expectoration is not well, very can not then lie down, have the fidgets etc.；
2nd, often because of climate flip, suffer from cold, or the factor such as some allergins of contact induces；Part can have infancy eczema history, or
Family's allergies；
3rd, heart and lung auscultation：Two lungs are abound with wheezing sound, expiratory flow retard, or news and bubble, increased heart rate；
4th, bronchial astehma, blood leukocytes sum is normal, and eosinophil can increase, suspicious allergen skin test Chang Chengyang
Property；During with pulmonary infection, blood leukocytes sum and neutrophil leucocyte can increase.
3rd, Standards of Chinese Medical Syndrome Differentiation
1st, cough and asthma even nares flaring, gurgling with sputum, asthma can not crouch, thirsty, there is sweat or lossless, and flushing is thirsty, and phlegm is sticky
Color is yellow, that tells unfavorable, rolling and rapid pulse, red tongue with yellowish fur.
2 or simultaneous on the basis of the 1 arteries and veins disease see that the cold-evil such as fever with aversion to cold, head-body-pain, floating pulse external beam shows.
4th, therapeutic scheme：During clinical practice, one portion per day, decocting takes juice about 400ml twice, point early, evening temperature on an empty stomach twice
Clothes, five are a course for the treatment of.
5th, criterion of therapeutical effect
1st, clinical cure：Asthma is calmed down, and the lung wheezing sound of auscultation two disappears；
2nd, it is effective：Asthma mitigates, and wheezing sound is occasionally heard in auscultation；
3rd, it is invalid：Asthma attack symptom is without improvement.
6th, therapeutic effect：In the clinical observation case, 6-12 courses for the treatment of of taking medicine, clinical cure 43, effective 12,
Invalid 5.Obvious effective rate 91.6%.Adverse drug reaction does not occur during treatment.
7th, model case
Peng, female, 60 years old.Asthma medical history 40 years, frequent recurrent exerbation, the autumn and winter are more so.This asthma attack is stated during examining to have held
More than the continuous moon, patient is suffered from cold flu again to examine proxima luce (prox. luc), and the state of an illness is aggravated, fever with aversion to cold, head-body-pain, gurgling with sputum, and asthma can not crouch,
The sticky phlegm of white is told, thirst, tongue nature is dark red, and thin white fur of tongue is dried, and the floating number of pulse condition is loud.The dialectical hot heavy breathing for cold bag heat
Asthma, 1 dose of traditional Chinese herbal decoction prepared by the Chinese medicine composition of the present invention is taken, next day further consultation, exterior syndrome complete solution, cough and asthma is light, but not yet
Stop completely, continue to take 1 course for the treatment of, cough and asthma is wholly absent, and shortness of breath is felt when only walking upstairs, after consolidate followed by taking 1 course for the treatment of
Gu treatment, pays a return visit after 1 year, tells that autumn and winter last year cough and asthma is not reaccessed, clinical cure.
8th, conclusion
Component science of the present invention, abundant raw material is cheap, reasonable compatibility, supports mutually, has facilitaing lung heat-clearing, relieving cough and asthma
And other effects, for curing mainly heat panting, card category is outer to be slightly cold, lung stagnated phlegm heat, accumulation of heat in the lung and cause cough and asthma even nares flaring, larynx
Middle gurgling weith sputum, asthma can not crouch, thirsty, there is sweat or lossless, and the sticky color of phlegm is yellow, that tells unfavorable, rolling and rapid pulse, red tongue with yellowish fur person.Also may be used
Treatment acute bronchitis, large and small leaf pneumonia etc. belongs to lung heat and makees asthma person.It was verified that Chinese medicine composition of the present invention is clinical
It is evident in efficacy, effectively control heat asthma acute attack can be reached and prevent the purpose of asthma recurrent exerbation, and nontoxic secondary work
With, it is safe, there is good application value and actual clinical meaning.
Claims (5)
1. a kind of Chinese medicine composition for treating heat asthma, it is characterised in that the Chinese medicine composition is by following parts by weight meter
Material medicine be made：9~12 parts of Chinese ephedra, 30~45 parts of gypsum, 9~12 parts of almond, 12~15 parts of the root bark of white mulberry, the root bark of Chinese wolf-berry 12
~15 parts, 9~12 parts of polished rice, 9~12 parts of bulbus fritillariae cirrhosae, 12~15 parts of radix glehniae, 12~15 parts of the tuber of dwarf lilyturf, 6~9 parts of licorice.
2. the Chinese medicine composition for the treatment of heat asthma according to claim 1, it is characterised in that by following parts by weight meter
Material medicine be made：9 parts of Chinese ephedra, 30 parts of gypsum, 9 parts of almond, 12 parts of the root bark of white mulberry, 12 parts of the root bark of Chinese wolf-berry, 9 parts of polished rice, tendril-leaved fritillary bulb
Female 9 parts, 12 parts of radix glehniae, 12 parts of the tuber of dwarf lilyturf, 6 parts of licorice.
3. the Chinese medicine composition for the treatment of heat asthma according to claim 1, it is characterised in that by the original of following weight meter
Material medicine is made：Chinese ephedra 10g, gypsum 40g, almond 11g, root bark of white mulberry 14g, root bark of Chinese wolf-berry 13g, polished rice 10g, bulbus fritillariae cirrhosae 11g, north
The root of straight ladybell 13g, tuber of dwarf lilyturf 13g, licorice 7g.
4. the Chinese medicine composition for the treatment of heat asthma according to claim 1, it is characterised in that by the original of following weight meter
Material medicine is made：Chinese ephedra 12g, gypsum 30g, almond 12g, root bark of white mulberry 15g, root bark of Chinese wolf-berry 12g, polished rice 9g, bulbus fritillariae cirrhosae 12g, north
The root of straight ladybell 12g, tuber of dwarf lilyturf 12g, licorice 9g.
5. the Chinese medicine composition for the treatment of heat asthma according to claim 1, it is characterised in that by the original of following weight meter
Material medicine is made：Chinese ephedra 11g, gypsum 35g, almond 10g, root bark of white mulberry 13g, root bark of Chinese wolf-berry 14g, polished rice 11g, bulbus fritillariae cirrhosae 10g, north
The root of straight ladybell 14g, tuber of dwarf lilyturf 14g, licorice 8g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710851970.6A CN107496745A (en) | 2017-09-20 | 2017-09-20 | A kind of Chinese medicine composition for treating heat asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710851970.6A CN107496745A (en) | 2017-09-20 | 2017-09-20 | A kind of Chinese medicine composition for treating heat asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107496745A true CN107496745A (en) | 2017-12-22 |
Family
ID=60696917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710851970.6A Pending CN107496745A (en) | 2017-09-20 | 2017-09-20 | A kind of Chinese medicine composition for treating heat asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107496745A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115350251A (en) * | 2022-09-29 | 2022-11-18 | 河南润弘本草制药有限公司 | A Chinese medicinal composition for treating cough with asthma due to lung-heat, and its preparation method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1196262A (en) * | 1998-05-15 | 1998-10-21 | 郝济民 | Formula of relieving asthma pill and preparation technology thereof |
| CN101766741A (en) * | 2008-12-31 | 2010-07-07 | 周国生 | Chinese medicine composite for treating heat asthma |
| CN101979056A (en) * | 2010-10-08 | 2011-02-23 | 黄岭 | Traditional Chinese medicament for treating asthma |
| CN104435644A (en) * | 2014-12-11 | 2015-03-25 | 青岛百瑞吉生物工程有限公司 | Traditional Chinese medicine preparation for treating asthma as well as preparation method and application of traditional Chinese medicine preparation |
-
2017
- 2017-09-20 CN CN201710851970.6A patent/CN107496745A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1196262A (en) * | 1998-05-15 | 1998-10-21 | 郝济民 | Formula of relieving asthma pill and preparation technology thereof |
| CN101766741A (en) * | 2008-12-31 | 2010-07-07 | 周国生 | Chinese medicine composite for treating heat asthma |
| CN101979056A (en) * | 2010-10-08 | 2011-02-23 | 黄岭 | Traditional Chinese medicament for treating asthma |
| CN104435644A (en) * | 2014-12-11 | 2015-03-25 | 青岛百瑞吉生物工程有限公司 | Traditional Chinese medicine preparation for treating asthma as well as preparation method and application of traditional Chinese medicine preparation |
Non-Patent Citations (2)
| Title |
|---|
| 杨丽萍: "《家庭必备偏验方系列 呼吸疾病偏验方》", 31 May 2017, 中国医药科技出版社 * |
| 邵念方: "《脏腑证治与用药》", 31 August 1983, 山东科学技术出版社 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115350251A (en) * | 2022-09-29 | 2022-11-18 | 河南润弘本草制药有限公司 | A Chinese medicinal composition for treating cough with asthma due to lung-heat, and its preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107596328A (en) | A kind of medicine for treating allergic rhinitis | |
| CN102302723A (en) | Traditional Chinese medicine preparation for eliminating phlegm and relieving cough | |
| CN102552778B (en) | Medicinal composition for treating cough, and preparation method and application thereof | |
| CN1201793C (en) | Medicine composition for treatment of cough and asthma and preparation thereof | |
| CN104189554A (en) | Traditional Chinese medicine patch for treating pediatric hot asthma and preparation method of traditional Chinese medicine patch | |
| CN101474377A (en) | Chinese medicine prescription for treating chronic bronchitis | |
| CN102091195B (en) | Medicament for treating snore and sleep apnea syndrome | |
| CN107496745A (en) | A kind of Chinese medicine composition for treating heat asthma | |
| CN104623555A (en) | Traditional Chinese medicine preparation for treating acute asthmatic bronchitis and preparation method thereof | |
| CN104274643B (en) | A kind of Chinese medicine for treating infantile pneumonia | |
| CN103463604A (en) | Drug for treating cough and asthma | |
| CN100364587C (en) | Acupoint selection strapping medicine for treating chronic bronchitis and bronchial asthma and its compounding method | |
| CN107617091A (en) | A kind of Chinese medicine composition for treating cold asthma | |
| CN106581585A (en) | Medicine composition for treating gastric ulcer | |
| CN106237056A (en) | A kind of Chinese medicine decoction treating chronic bronchitis | |
| CN105963501A (en) | Method for preparing traditional Chinese medicine composition for treating infantile asthma | |
| CN107582834A (en) | A kind of Chinese medicine composition for treating empty asthma | |
| CN104189076B (en) | A kind of Traditional Chinese medicine plaster for treating children's cold asthma and preparation method thereof | |
| CN102727614B (en) | Chinese-western medicine preparation for treating chronic obstructive pulmonary disease | |
| CN108815438A (en) | A kind of pharmaceutical composition for treating chronic obstructive pulmonary disease | |
| CN102274428A (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN106668669A (en) | Traditional Chinese medicine formula for treating cough variant asthma | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN105902735A (en) | Traditional Chinese medicine composition for treating asthmatic bronchitis | |
| CN105232816A (en) | Traditional Chinese medicine for treating vocal cord paralysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171222 |